Deepak Bhatt named Senior Associate Editor for Journal of Invasive Cardiology

Malvern, PA. – May 3, 2012 – Deepak L. Bhatt, MD, MPH, Chief of Cardiology at VA Boston Healthcare System and Director of the Integrated Interventional Cardiovascular Program at Brigham and Women’s Hospital and VA Boston Healthcare System has been named senior associate editor of the Journal of Invasive Cardiology. Dr. Bhatt is also a Senior Investigator in the TIMI Study Group and an Associate Professor of Medicine at Harvard Medical School.

The Journal of Invasive Cardiology (JIC), a monthly, peer-reviewed scientific journal, was launched in 1988 to provide a focused, definitive source for cardiovascular specialists to keep up-to-date on advances in this rapidly changing field. The journal publishes original research articles on clinical trials of therapeutic devices, drugs used in the catheterization laboratory and in post-PCI therapy, comparison of treatment modalities and long-term evaluation of therapy, case reports on current innovations in clinical practice, in-depth reviews, and expert commentaries, brief communications and new techniques in this rapidly advancing specialty. The journal also regularly updates readers about emerging areas such as cellular therapy and advances in percutaneous valve repair.

“The Journal of Invasive Cardiology continues to lead in providing relevant scientific information with immediate clinical applicability to help provide patients with the best possible cardiovascular care,” said Dr. Bhatt. “I look forward to my collaboration with the journal in continuing this important work.”

Effective with the June 2012 issue, Bhatt will work closely with JIC’s editor-in-chief Richard E. Shaw, PhD. Dr. Shaw has been associated for many years with the American College of Cardiology-National Cardiovascular Data Registry (ACC-NCDR), honored as a “Founding Father” of the NCDR, a past member of the Executive management board of the NCDR, author of the charter and first chair for the Science Oversight committee governing all ACC-NCDR registries, executive steering committee member for the ACC/STS/FDA collaboration, and prior chair of the data element steering committees for both Cath/PCI version 3.0 and ACTION 2.0 datasets.

The two also have a long history working together on the journal, as Dr. Bhatt has served as a board member for eleven years. “Dr. Bhatt brings a vast research and publication experience to JIC from his leadership roles in multiple academic organizations and his widespread publication of cutting edge research in major medical journals. His expertise and depth of experience will contribute to the growth of JIC and its prominence in the world of Cardiology publications,” noted Shaw. From 2004 to 2008, Dr. Bhatt served as section editor of JIC’s special section on adjunctive therapies. During that time he invited numerous review articles to elucidate the advances in this area for journal readers.

Dr. Bhatt received his undergraduate science degree as a National Merit Scholar at the Massachusetts Institute of Technology while also serving as a research associate at Harvard Medical School. He received his medical doctorate from Cornell University and completed a Masters in Public Health with a concentration in clinical effectiveness at Harvard University. His internship and residency in internal medicine were performed at the Hospital of the University of Pennsylvania, and his cardiovascular training was completed at Cleveland Clinic. He also completed fellowships in interventional cardiology and cerebral and peripheral vascular intervention, as well as serving as Chief Interventional Fellow, at Cleveland Clinic where he went on to spend several years as an interventional cardiologist and an Associate Professor of Medicine. He served for many years as Director of the Interventional Cardiology Fellowship and as Associate Director of the Cardiovascular Medicine Fellowship. He also served as Associate Director of the Cleveland Clinic Cardiovascular Coordinating Center. Dr. Bhatt was listed in Best Doctors in America from 2005 to 2012.

Dr. Bhatt’s research interests include preventive cardiology, as well as the optimal management of patients with acute coronary syndromes. He also has research interests in advanced techniques in cardiac, cerebral, and peripheral intervention. He has authored or co-authored over 500 publications. He is on several editorial boards. He is the editor of Essential Concepts in Cardiovascular Intervention and Guide to Peripheral and Cerebrovascular Intervention, as well as co-editor of the Handbook of Acute Coronary Syndromes. He was the international PI for the CHARISMA and CRESCENDO trials and co-PI of the CHAMPION trials. He served as chair of the COGENT trial and helped lead the STAMPEDE trial. He serves as the co-chair of the REACH registry. He is also on the steering committees of several trials. He is the current Chair of the AHA-GWTG Science Subcommittee. He is the Associate Editor for clinical trials for the ACC’s Cardiosource. Dr. Bhatt has been a visiting lecturer at a number of prestigious institutions throughout the world. He has been interviewed extensively by news agencies on topics ranging from premature coronary artery disease to the role of inflammation and genetics in heart attacks.

“Dr Bhatt has been involved in a broad range of key research activities while maintaining a busy interventional practice. His contributions have honestly helped to create a better world for those with cardiovascular disease. He’s got a great sense of perspective, and with his vision and experience, he’s an ideal choice as a senior associate editor for the Journal” said Kirk N. Garratt, MSc, MD, Associate Director, Division of Cardiac Interventions, Clinical Director, Interventional Cardiovascular Research, Director, Process Improvement and Quality, Interventional Cardiology, Director, Interventional Cardiovascular Fellowship Program at Lenox Hill Heart and Vascular Institute of New York.

The Journal of Invasive Cardiology is the official journal of the prestigious International Andreas Gruentzig Society, of which both Dr. Bhatt and Dr. Shaw are members. The journal, which is approaching its 25th year anniversary in 2013, is cited by Index Medicus/Pubmed and ISI/Current Contents/Clinical Medicine and SCIE. It is available at A yearly subscription to the journal is sent without charge to qualified interventionists in the United States; others in the U.S receive JIC for $143 and the cost is $242 for those outside the U.S.

HMP Communications
HMP Communications (HMP) is the authoritative source for comprehensive information and education serving healthcare professionals. HMP’s products include medical journals, national trade shows and conferences, online programs and customized programs within the clinical areas of wound care, dermatology, podiatry, cardiology, vascular, electrophysiology, long-term care, diabetes, arthritis, and specialized primary care. Discover more about HMP’s products and services at

Back to top